Sofinnova Venture Partners IX, L.P.

Track

Insider profile

Performance

Overall performance
3.6
Performance over holding periods
3.6
30 days 90 days 120 days
Average return 27% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
2 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Sofinnova Venture Partners IX, L.P.'s trades of Iterum Therapeutics PLC's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2020-06-03 2020-06-02
S Sale
84,118 -13.3%
462.49
US$1,473,855 		84,118 -13.3% 462.49 US$1,473,855
2020-06-03 2020-06-01
S Sale
83,648 -10.4%
51.22
US$398,265 		83,648 -10.4% 51.22 US$398,265
2019-05-15 2019-05-13
US NextCure Inc (NXTC)
B Purchase
70,639 +6.6%
392.62
US$1,827,520 		70,639 +6.6% 392.62 US$1,827,520